Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Lutetium-177

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nusano, Ariceum Therapeutics Ink Multi-Isotope Supply Deal
    Nusano, Ariceum Therapeutics Ink Multi-Isotope Supply Deal

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166030/0/en/Nusano-and-Ariceum-Therapeutics-Announce-Multi-Isotope-Supply-Agreement.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    C-Ray Backs Mednovo Ph 3 Trial, First Patient Dosed With 177Lu
    C-Ray Backs Mednovo Ph 3 Trial, First Patient Dosed With 177Lu

    10 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/c-ray-therapeutics-supports-mednovos-phase-iii-clinical-trial-with-first-patient-dosed-for-lutetium-177lu-oxodotreotide-injection-302552536.html

    PR NEWSWIRE
    10 Sep 2025
    Share Share
    Blue Earth Shares Ph1 Data on 177Lu rhPSMA-10.1 at SNMMI
    Blue Earth Shares Ph1 Data on 177Lu rhPSMA-10.1 at SNMMI

    25 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/blue-earth-therapeutics-snmmi-presentation-of-results-from-lutetium-177lu-rhpsma-10-1-injection-phase-1-clinical-trial-302490153.html

    PR NEWSWIRE
    25 Jun 2025
    Share Share
    Blue Earth Therapeutics starts Phase 2 Trial for Lutetium (177Lu)
    Blue Earth Therapeutics starts Phase 2 Trial for Lutetium (177Lu)

    01 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/blue-earth-therapeutics-initiates-phase-2-clinical-trial-evaluating-the-efficacy-and-safety-of-lutetium-177lu-rhpsma-10-1-injection-in-metastatic-castrate-resistant-prostate-cancer-302441668.html

    PR NEWSWIRE
    01 May 2025
    Share Share
    Eckert & Ziegler, AtomVie Sign Global Deal For Lu-177 Supply
    Eckert & Ziegler, AtomVie Sign Global Deal For Lu-177 Supply

    20 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eckert--ziegler-and-atomvie-global-radiopharma-sign-a-global-agreement-for-lutetium-177-supply-302406500.html

    PR NEWSWIRE
    20 Mar 2025
    Share Share
    Blue Earth Therapeutics Reports Key Results from Lutetium rhPSMA-10.1
    Blue Earth Therapeutics Reports Key Results from Lutetium rhPSMA-10.1

    13 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/blue-earth-therapeutics-reports-key-results-from-lutetium-177lu-rhpsma-10-1-injection-phase-1-clinical-trial-302400601.html

    PR NEWSWIRE
    13 Mar 2025
    Share Share